Active Motif | GenomeWeb

Active Motif

The partners plan to improve yields from small input samples and provide better sequencing libraries.

TimeLogic, a division of Active Motif, said this week that Ghent University has implemented the latest version of its J-Series Field Programmable Gate Array-based DeCypher system, adding to an earlier version of the infrastructure already installed at the institution.

TimeLogic, an Active Motif subsidiary, said this week that the Center for Biotechnology (CeBiTec) at Bielefeld University has added the latest version of its J-series field programmable gate array hardware to its suite of computational tools.

NEW YORK (GenomeWeb News) – VolitionRx said today it has reached a deal with Active Motif to co-exclusively distribute VolitionRx's NuQ product line in Europe, the US, and Japan.

Active Motif's TimeLogic has released an updated version of Tera-BLAST, its field programmable gate array-based implementation of the Basic Local Alignment Search Tool.

NEW YORK (GenomeWeb News) – Active Motif announced Thursday that it has acquired privately held genomics tools maker SwitchGear Genomics for an undisclosed price.

Active Motif subsidiary TimeLogic said this week that Australia's Southern Cross University will use its field programmable gate array-based DeCypher system to analyze genetic data for plant-based research projects.

Active Motif subsidiary TimeLogic said this week that the Rothamsted Research, a UK-based agricultural research institute, has purchased the latest version of its DeCypher system to enhance its high-throughput genome annotation efforts.

TimeLogic, a division of Active Motif, said this week that it is partnering with Bielefeld University's Center for Biotechnology to build faster versions of sequence comparison algorithms that will run on its field programmable gate array-based DeCypher biocomputing system.

Genedata has released version 2.0 of its Genedata Biologics data-management product for biologics R&D.

Pages

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.